Showing 1 posts of 1 posts found.
Emmaus Medical has been handed approval for the first new treatment for sickle cell disease in two decades. The active …
Envirogen secures place on NHS Scotland reverse osmosis framework
Europa Biosite enters Czech market with acquisition of diagnostics distributor
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment